Lineage Cell Therapeutics (LCTX) Times Interest Earned (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly Times Interest Earned came in at -$0.65 in Q1 2026, up 96.97% year-on-year from -$0.33 in Q1 2025, and down 107.18% quarter-over-quarter from $9.01 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Times Interest Earned (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Times Interest Earned history runs 16 years deep, the most recent figure standing at -$0.65 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 96.97% year-over-year to -$0.65 in Q1 2026; TTM through Mar 2026 was -$3.21, a 123.63% decrease from a year earlier, with the FY2025 full-year figure at -$0.41, down 64.58% from the prior year.
- Times Interest Earned declined to -$0.65 in Q1 2026 per LCTX's latest filing, from $9.01 in the prior quarter.
- Across five years, Times Interest Earned topped out at $12.6 in Q4 2022 and bottomed at -$84.68 in Q2 2022.
- The 5-year median for Times Interest Earned is -$7.18 (2025), against an average of -$11.19.
- Across the five-year window, Times Interest Earned soared 111.06% in 2022 and plunged 698.55% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $12.6 in 2022, then fell by 20.22% to $10.05 in 2023, then decreased by 28.69% to $7.17 in 2024, then gained by 25.67% to $9.01 in 2025, then tumbled by 107.18% to -$0.65 in 2026.
- Per Business Quant, the three latest LCTX Times Interest Earned figures stand at -$0.65 (Q1 2026), $9.01 (Q4 2025), and -$0.25 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | -0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.65 |
| Dec 31, 2025 | 9.01 |
| Sep 30, 2025 | -0.25 |
| Jun 30, 2025 | -7.18 |
| Mar 31, 2025 | -21.33 |
| Dec 31, 2024 | 7.17 |
| Sep 30, 2024 | -5.26 |
| Jun 30, 2024 | -8.10 |
| Mar 31, 2024 | -2.67 |
| Dec 31, 2023 | 10.05 |
| Sep 30, 2023 | -39.44 |
| Jun 30, 2023 | -11.09 |
| Mar 31, 2023 | -13.07 |
| Dec 31, 2022 | 12.60 |
| Sep 30, 2022 | -10.26 |
| Jun 30, 2022 | -84.68 |
| Mar 31, 2022 | -25.08 |
| Dec 31, 2021 | -113.86 |
| Sep 30, 2021 | -14.88 |
| Jun 30, 2021 | -15.39 |